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AbstractObjective
To examine changes in common cold symptoms and mouth ulcers following smoking 
cessation. It was hypothesised that occurrence of these symptoms would increase on 
stopping smoking would predict relapses to smoking.
Design  
A single cohort of smokers was assessed one week before stopping smoking 
(baseline), then after one, two and six weeks of smoking cessation.   
Participants
174 smokers attending a seven week smoking cessation programme combining 
weekly behavioural support with nicotine replacement therapy.
Setting
Community-based smoking cessation clinic.
Main outcome measures
Self-reports of cold symptoms, mouth ulcers and smoking abstinence (validated using 
expired carbon monoxide) were recorded on each measurement occasion.
Results   
Following one, two and six weeks of smoking abstinence 73.0% (127/174), 57.5% 
(100/174) and 44.8% (78/174) of the participants, respectively, maintained continuous 
abstinence and provided self-reports of cold symptoms and mouth ulcers. Relative to 
baseline, a significant increase in reports of cold symptoms was observed following 
one week of smoking abstinence (p=0.007) and an increase in reports of ulcers after 
one and two weeks of abstinence (p=0.012, p=0.039, respectively). The finding for 
increases in ulcers during the first week of stopping smoking predicting smoking 
relapses after two weeks of abstinence approached significance (p=0.072).
ConclusionsSmokers trying to stop need to be informed that they have an increased chance of 
experiencing a temporary increase in cold symptoms and mouth ulcers on stopping 
smoking. Being psychologically prepared for these effects may reduce their impact on 
the attempt to stop smoking. 
What this paper adds:
Clinical observation indicates that some smokers experience an increase in common 
cold symptoms and aphthous (mouth) ulcers on stopping smoking. Anecdotal reports 
suggest that the discomfort associated with these symptoms may act as a deterrent to 
successful smoking cessation. Until now no study has systematically monitored 
changes in reports of mouth ulcers and cold symptoms on stopping smoking.
The results of this study indicate that smokers have an increased chance of 
experiencing cold symptoms during the first week, and an increase in mouth ulcers for 
up to two weeks, following abstinence from smoking. Neither increases in ulcers, nor 
increases in cold symptoms, were related to relapsing to smoking, although the 
finding for ulcers approached significance. These results confirm clinical observations 
of increases in colds and ulcers on stopping smoking and suggest that smokers who 
are preparing to stop should be informed of their increased susceptibility to these 
symptoms. Introduction
The incidence of aphthous (mouth) ulcers has been found to be lower in smokers than 
in non-smokers [1] and clinical observation suggests that some smokers experience an 
increase in mouth ulcers on stopping smoking. Conversely, smokers tend to be more 
susceptible than non-smokers to developing common cold symptoms [2, 3], with 
clinical observations suggesting that some smokers experience an increase in cold 
symptoms on stopping smoking. In addition, anecdotal reports from smokers suggest 
that the discomfort associated with both mouth ulcers and cold symptoms may act as a 
deterrent to successful smoking cessation. To date, there has been no research 
systematically measuring changes in cold symptoms and mouth ulcers on stopping 
smoking. The present study aimed to examine changes in these symptoms through 




One hundred and seventy four men and women wanting to stop smoking, aged 18 to 
65 years and smoking at least 10 cigarettes a day for at least three years were recruited 
through newspaper advertisements across a twelve month period. Those with a 
psychiatric illness, substance misuse problem or pregnancy were excluded. The 
smokers provided written consent and ethics approval was obtained.
Design and measures
All participants were assessed one week before stopping smoking (baseline), and then 
after one, two and six weeks of smoking cessation. They attended six weekly smoking 
cessation treatment sessions involving individual cognitive-behavioural support [4] 
and a follow-up session two weeks after the final treatment. Participants were required to cease smoking at the second session and were advised to use 15mg 16 hour nicotine 
patches on a daily basis [5, 6]. 
At the first session demographic data were collected. Self-reports of continuous 
smoking abstinence [7] following one, two and six weeks of abstinence were verified 
with expired carbon monoxide (CO, cut-off 10ppm) using a Bedfont Smokerlyzer and 
participants reported on their use of nicotine patches. At the first session, then 
following one, two and six weeks of smoking abstinence, those participants 
maintaining continuous abstinence were asked 'Have you had any of the following 
cold symptoms in the last week': sore/scratchy throat, cough, blocked-up nose, runny 
nose, sneezing, off-colour, fever, chill, head-ache, muscle-ache, catarrh, feeling of 
deafness/muzziness in ears, ear-ache and temperature[8]. For each smoker, scores 
were summed at each measurement point to produce a composite cold symptoms 
score (range=0-14). Additionally, participants were asked ‘Have you had any mouth 
ulcers in the last week?’. 
Data analysis
All data were analysed using SPSS version 10. Changes in cold symptoms were 
examined using Wilcoxon tests. Changes in ulcers were assessed using pair-wise 
binomial tests. Logistic regression analyses was used to determine whether increases 
in symptoms predicted rates of smoking relapse. The association between changes in 
mouth ulcers and changes in cold symptoms was examined using a Spearman test. All 
statistical tests were two-tailed.
Results
The baseline characteristics of the sample are presented in table 1. Following one week, two weeks and six weeks of smoking abstinence 73.0% (127/174), 57.5% 
(100/174) and 44.8% (78/174) of the participants, respectively, maintained continuous 
abstinence and provided self-reports for cold symptoms and mouth ulcers. Of those 
abstinent for one, two and six weeks 91.3% (116/127), 87.0% (87/100) and 65.4% 
(51/78), respectively, reported using nicotine patches on a daily basis.
Wilcoxon tests showed that significantly more cold symptoms were reported 
relative to baseline following one week of smoking abstinence (Z=-2.7, p=0.007, 
mean (SD) scores (range=0-14, n=127): baseline=1.5 (2.2), one week=2.2 (2.7), 
although not after two weeks of abstinence (p=0.185, mean (SD) scores (n=100): 
baseline=1.4 (2.1), one week=1.9 (2.7)), or six weeks of abstinence (p=0.220, mean 
(SD) scores (n=78): baseline=1.4 (2.1), one week=1.8 (2.9). Following one week of 
abstinence, the most frequently reported cold symptoms were cough (28.3%, 36/127), 
runny nose (26.8%, 34/127), sneeze (26.0%, 33/127), sore/scratchy throat (25.2%, 
32/127), and blocked nose (19.7%, 25/127). This is consistent with previous reports of 
symptom prevalence for the common cold in the general population [9].
The absolute percentage of the participants reporting mouth ulcers at baseline was 
1.7% (3/174, 95% Confidence Interval (CI)=3.6%-4.9%). Pair-wise binomial tests 
showed a significant increase in reports of mouth ulcers relative to baseline following 
both one week of smoking abstinence (p=0.012; baseline=1.6%, 2/127, 95% CI=
0.2%-5.6%; one week=13.4%, 17/127, 95% CI=7.5%-19%) and two weeks of 
abstinence (p=0.039; baseline=2.0%, 2/100, 95% CI=0.2%-7.0%; two weeks=9.0% 
(9/100), 95% CI=4.2%-16.4%), although not after six weeks of abstinence (p=0.070; 
baseline=1.3%, 1/78, 95% CI=0.03%-6.9%; six weeks=9.0%, 7/78, 95% CI=3.7%-
17.6%)).
There was no significant association between increase in mouth ulcers and increase in cold symptoms between baseline and one week of smoking abstinence 
(point-biserial correlation coefficient=-0.101, p=0.472). Neither increases in cold 
symptoms nor increases in mouth ulcers following one week of smoking abstinence 
predicted smoking relapses at two weeks (p=0.299, 0.072, respectively) or six weeks 
(p=0.781, 0.290, respectively).
Discussion
This study provides evidence for there being an increase in cold symptoms following 
one week of smoking cessation and an increase in mouth ulcers for two weeks 
following cessation. The lack of an association between reports of cold symptoms and 
reports of mouth ulcers suggests that different mechanisms may underlie the effect of 
smoking cessation on these symptoms. One explanation for the observed increase in 
mouth ulcers following smoking cessation is the absence of the anti-bacterial effect of 
smoking[9]. The increase in reports of cold symptoms could be explained by a 
reduction in salivary immunoglobulin A levelson stopping smoking[10]. Studies are 
needed to investigate possible psychological and physiological mechanisms 
underlying the reported changes in symptoms after smoking cessation.
In the present study, since recruitment was staggered over a 12 month period, and 
since the increases in symptoms were only observed up to three weeks following the 
baseline measures, the chances of any effects being the result of seasonal variations 
were very small. Interestingly, when examining whether increases in ulcers predicted 
two weeks of smoking abstinence the finding approached significance (p=0.072, two-
tailed). In order to adequately assess the impact of increases in ulcers and cold 
symptoms on rates of smoking abstinence further studies are required with larger 
sample sizes. Furthermore, it would be useful to assess the extent to which smokers relate the occurrence of these symptoms to a smoking relapse.
The decreased sample size following two weeks and six weeks of smoking 
abstinence reduced the chance of detecting significant changes in cold symptoms and 
ulcers at these times. Further studies with larger sample sizes are needed in order to 
examine whether cold symptoms are elevated beyond one week of smoking 
abstinence and ulcers beyond two weeks of abstinence. In order to adequately control 
for seasonal variations a control group of continuing smokers would be required.
The results of this study have implications for the smoker who is trying to stop. 
Smokers need to be informed that they have an increased chance of experiencing a 
transient elevation in cold symptoms and mouth ulcers on stopping smoking. Being 
psychologically prepared for these effects is likely to mitigate their impact on the 
cessation attempt. Previously it has been shown that having realistic expectations of 
the consequences of medical interventions increases patient satisfaction and aids in 
decision making concerning treatment options [11,12]. 
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Update Software, 2001. Table 1. - Baseline characteristics of the study sample (n=174)
Characteristic Mean (SD) 95% CIs
Age (years) 43.2 (11.4) 41.5-44.9
Education (years) 13.0 (3.3)     12.5-13.5
Fagerström Test for Nicotine Dependence score   5.5 (2.0)       5.2-5.8
Smoking rate, cigarettes a day 21.3 (8.0) 20.1-22.5
Carbon monoxide level (ppm) 21.3 (9.0) 20.0-22.6
Number (%)
Female 108 (62.1) 54.9-69.3
Married   98 (56.3)     49.0-63.7
Professional/managerial   80 (46.0) 38.6-53.4
Caucasian 153 (87.9) 83.1-92.8
ppm=parts per million